Cardiovascular Toxicities of Androgen Deprivation Therapy

Prostate cancer is the second leading cause of cancer death in men, and cardiovascular disease is the number one cause of death in patients with prostate cancer. Androgen deprivation therapy, the cornerstone of prostate cancer treatment, has been associated with adverse cardiovascular events. Emergi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Treat Options Oncol
Autori principali: Challa, Azariyas A., Calaway, Adam Christopher, Cullen, Jennifer, Garcia, Jorge, Desai, Nihar, Weintraub, Neal L., Deswal, Anita, Kutty, Shelby, Vallakati, Ajay, Addison, Daniel, Baliga, Ragavendra, Campbell, Courtney M., Guha, Avirup
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2021
Soggetti:
Cardio-oncology (MG Fradley, Section Editor)
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8053026/
https://ncbi.nlm.nih.gov/pubmed/33866442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-021-00846-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi